İpucu modu açıktır Kapat
Bölümler arasında hızlı gezinim için

Kuruluş: NewAmsterdam Pharma
LEI 984500B6549TF6E14D36

Kuruluş adı
NewAmsterdam Pharma Co NV
Ülke adı
Hollanda
Kayıt ülkesi
Hollanda
Endüstri
İlaç üretimi ve biyoteknoloji
Tahvil borcu
-

en kapsamlı veri tabanını keşfedin

800 000

dünya çapinda tahvi̇ller

400'den fazla

fiyatlandırma kaynakları

80 000

hisse senetleri

9 000

ETF

Portföyünüzü en etkili şekilde takip edin
tahvi̇l arama
Watchlist
Excel Eklentisi
Erişim sağlamak

Şu tarihe ilişkin son veriler

Kotasyonlar

Talep gönderildi
Erişim reddedildi
Talep gönder
Bilgi sağlayıcılarının sunduğu kotasyonlar, gösterge niteliğindedir

Profil

NewAmsterdam Pharma operates as a pharmaceutical company. The Company focuses on the research and development of transformative therapies for cardio-metabolic diseases. NewAmsterdam Pharma serves customers in the Netherlands.

Ödüller

Haberler

09.05.2024 NewAmsterdam Pharma: Results Of Operations And Financial Condition, Financial Statements And Exhibits
28.03.2024 NewAmsterdam Pharma: , Including Exhibit 99.1, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended (the Securities Act ). The Information Contained In This Item 7.01, Including Exhibit 99.1, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
04.03.2024 NewAmsterdam Pharma: , Including Exhibit 99.1, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended (the Securities Act ). The Information Contained In This Item 7.01, Including Exhibit 99.1, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
28.02.2024 NewAmsterdam Pharma: Of This Current Report On Form, Financial Statements And Exhibits
13.02.2024 NewAmsterdam Pharma: The Information Contained In This Item 7.01, Including Exhibits 99.1 And 99.2, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act. The Information Contained In This Item 7.01, Including Exhibits 99.1 And 99.2, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
Kuruluşla ilgili tüm haberler

Dokümantasyon

UFRS/ABD GAAP raporlaması

2024
I çyr. İngilizce
2023
IV çyr. İngilizce
2022
IV çyr. İngilizce
Hepsini göster Gizle
Giriş yapmalısınız
Bir başvuru formu gönderin erişimler

Hisse Senetleri

Para birimine göre tahvil borcu

Tümünü göster Gizle

Kodlar

  • LEI
    984500B6549TF6E14D36
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001936258

Kredi ve ESG derecelendirmeleri

Makroekonomik Göstergeler - NewAmsterdam Pharma

Kayıt gereklidir erişim için